Yuki Shinohara

Dr. Yuki Shinohara

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2010 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
MIMasanobu Ibaraki
Masanobu Ibaraki
YSYuki Shinohara
Yuki Shinohara
KNKazuhiro Nakamura
Kazuhiro Nakamura
SMShuichi Miura
Shuichi Miura
FKFumiko Kinoshita
Fumiko Kinoshita
TKToshibumi Kinoshita
Toshibumi Kinoshita
Regional cerebral blood flow (CBF) and oxygen metabolism can be measured by positron emission tomography (PET) with 15O-labeled compounds. Hemoglobin (Hb) concentration of blood, a primary determinant of arterial oxygen content (CaO2), influences cerebral circulation. We investigated interindividual variations of CBF, cerebral blood volume (CBV), oxygen extraction fraction (OEF), and cerebral metabolic rate of oxygen (CMRO2) in relation to Hb concentration in healthy human volunteers ( n=17) and in patients with unilateral steno-occlusive disease ( n=44). For the patients, data obtained only from the contralateral hemisphere (normal side) were analyzed. The CBF and OEF were inversely correlated with Hb concentration, but CMRO2 was independent of Hb concentration. Oxygen delivery defined as a product of CaO2 and CBF (CaO2 CBF) increased with a rise of Hb concentration. The analysis with a simple oxygen model showed that oxygen diffusion parameter ( L) was constant over the range of Hb concentration, indicating that a homeostatic mechanism controlling CBF is necessary to maintain CMRO2. The current findings provide important knowledge to understand the control mechanism of cerebral circulation and to interpret the 15O PET data in clinical practice.

6 June 2013 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
FMF. Miyoshi
F. Miyoshi
TOT. Ogawa
T. Ogawa
SKS.-I. Kitao
S.-I. Kitao
MKM. Kitayama
M. Kitayama
YSYuki Shinohara
Yuki Shinohara
TKT. Kaminou
T. Kaminou
BACKGROUND AND PURPOSE: Progressive changes in the substantia nigra pars compacta and locus ceruleus of patients with Parkinson disease and Alzheimer disease visualized by neuromelanin MRI and cardiac postganglionic sympathetic nerve function on 123I-metaiodobenzylguanidine scintigraphy have not been fully evaluated. We compared the diagnostic value of these modalities among patients with early Parkinson disease, late Parkinson disease, and Alzheimer disease. MATERIALS AND METHODS: We compared contrast ratios of signal intensity in medial and lateral regions of the substantia nigra pars compacta and locus ceruleus with those of the tegmentum of the midbrain and the pons, respectively, by use of neuromelanin MRI in patients with early Parkinson disease (n = 13), late Parkinson disease (n = 31), Alzheimer disease (n = 6), and age-matched healthy control subjects (n = 20). We calculated heart-to-mediastinum ratios on 123I-metaiodobenzylguanidine scintigrams after setting regions of interest on the left cardiac ventricle and upper mediastinum. RESULTS: The signal intensity of the lateral substantia nigra pars compacta on neuromelanin MRI was significantly reduced in early and late Parkinson disease, and that of the medial substantia nigra pars compacta was gradually and stage-dependently reduced in Parkinson disease. The signal intensity of the locus ceruleus was obviously reduced in late Parkinson disease. Signal reduction was not significant in the substantia nigra pars compacta and locus ceruleus of patients with Alzheimer disease. The heart-to-mediastinum ratio on 123I-metaiodobenzylguanidine scintigrams was stage-dependently reduced in Parkinson disease and normal in Alzheimer disease. The signal intensity ratios in substantia nigra pars compacta and locus ceruleus on neuromelanin MRI positively correlated with the heart-to-mediastinum ratio on 123I-metaiodobenzylguanidine scintigrams. CONCLUSIONS: Both neuromelanin MRI and 123I-metaiodobenzylguanidine scintigraphy can help to evaluate disease progression in Parkinson disease and are useful for differentiating Parkinson disease from Alzheimer disease.

16 January 2016 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
KKKeita Kuya
Keita Kuya
YSYuki Shinohara
Yuki Shinohara
FMFuminori Miyoshi
Fuminori Miyoshi
SFShinya Fujii
Shinya Fujii
YTYoshio Tanabe
Yoshio Tanabe
TOToshihide Ogawa
Toshihide Ogawa

1 October 2014 in Acta Radiologica
Verified
Journal Article
Closed access
YSYuki Shinohara
Yuki Shinohara
MSMakoto Sakamoto
Makoto Sakamoto
NINaoki Iwata
Naoki Iwata
JKJunichi Kishimoto
Junichi Kishimoto
KKKeita Kuya
Keita Kuya
TOToshihide Ogawa
Toshihide Ogawa
Background: Recently, a newly developed fast-kV switching dual energy CT scanner with a gemstone detector generates virtual high keV images as monochromatic imaging (MI). Each MI can be reconstructed by metal artifact reduction software (MARS) to reduce metal artifact. Purpose: To evaluate the degree of metal artifacts reduction and vessel visualization around the platinum coils using dual energy CT with MARS. Material and Methods: Dual energy CT was performed using a Discovery CT750 HD scanner (GE Healthcare, Milwaukee, WI, USA). In a phantom study, we measured the mean standard deviation within regions of interest around a 10-mm-diameter platinum coil mass on MI with and without MARS. Thirteen patients who underwent CTA after endovascular embolization for cerebral aneurysm with platinum coils were included in a clinical study. We visually assessed the arteries around the platinum coil mass on MI with and without MARS. Results: Each standard deviation near the coil mass on MI with MARS was significantly lower than that without MARS in a phantom study. On CTA of a clinical study, better visibility of neighboring arteries was obtained in 11 of 13 patients on MI with MARS compared to without MARS due to metal artifact reduction. Conclusion: Dual energy CT with MARS reduces metal artifact of platinum coils, resulting in favorable vessel visualization around the coil mass on CTA after embolization.

1 January 2018 in Yonago Acta Medica
Verified
Journal Article
Open access
PDF file
TOToshihide Ogawa
Toshihide Ogawa
SFShinya Fujii
Shinya Fujii
KKKeita Kuya
Keita Kuya
SKShin-Ichiro Kitao
Shin-Ichiro Kitao
YSYuki Shinohara
Yuki Shinohara
YTYoshio Tanabe
Yoshio Tanabe
An accurate diagnosis of Parkinson’s disease (PD) is a prerequisite for therapeutic management. In spite of recent advances in the diagnosis of parkinsonian disorders, PD is misdiagnosed in between 6 and 25% of patients, even in specialized movement disorder centers. Although the gold standard for the diagnosis of PD is a neuropathological assessment, neuroimaging has been playing an important role in the differential diagnosis of PD and is used for clinical diagnostic criteria. In clinical practice, differential diagnoses of PD include atypical parkinsonian syndromes such as dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, caused by a striatal dopamine deficiency following nigrostrial degeneration. PD may also be mimicked by syndromes not associated with a striatal dopamine deficiency such as essential tremor, drug-induced parkinsonism, and vascular parkinsonism. Moreover, difficulties are associated with the clinical differentiation of patients with parkinsonism from those with Alzheimer’s disease. In this review, we summarize the typical imaging findings of PD and its related diseases described above using morphological imaging modalities (conventional MR imaging and neuromelanin MR imaging) and functional imaging modalities (99mTc-ethyl cysteinate dimer perfusion single photon emission computed tomography, 123I-metaiodobenzylguanidine myocardial scintigraphy, and 123I-FP-CIT dopamine transporter single photon emission computed tomography) that are clinically available in most hospitals. We also attempt to provide a diagnostic approach for the differential diagnosis of PD and its related diseases in clinical practice.

31 October 2019 in Japanese Journal of Radiology
Verified
Journal Article
Closed access
PDF file
YSYuki Shinohara
Yuki Shinohara
NTNoriyuki Takahashi
Noriyuki Takahashi
YLYongbum Lee
Yongbum Lee
TOTomomi Ohmura
Tomomi Ohmura
TKToshibumi Kinoshita
Toshibumi Kinoshita